BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31532297)

  • 1. IQOS - a heat-not-burn (HnB) tobacco product - chemical composition and possible impact on oxidative stress and inflammatory response. A systematic review.
    Kopa PN; Pawliczak R
    Toxicol Mech Methods; 2020 Feb; 30(2):81-87. PubMed ID: 31532297
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the effects of active and passive smoking of tobacco cigarettes, electronic nicotine delivery systems and tobacco heating products on the expression and secretion of oxidative stress and inflammatory response markers. A systematic review.
    Kopa-Stojak PN; Pawliczak R
    Inhal Toxicol; 2024 Feb; 36(2):75-89. PubMed ID: 38394073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IQOS
    Adriaens K; Gucht DV; Baeyens F
    Int J Environ Res Public Health; 2018 Dec; 15(12):. PubMed ID: 30567400
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in Biomarkers of Exposure on Switching From a Conventional Cigarette to Tobacco Heating Products: A Randomized, Controlled Study in Healthy Japanese Subjects.
    Gale N; McEwan M; Eldridge AC; Fearon IM; Sherwood N; Bowen E; McDermott S; Holmes E; Hedge A; Hossack S; Wakenshaw L; Glew J; Camacho OM; Errington G; McAughey J; Murphy J; Liu C; Proctor CJ
    Nicotine Tob Res; 2019 Aug; 21(9):1220-1227. PubMed ID: 29912406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine Delivery of a Menthol-Flavored Heat-not-Burn Tobacco Product During Directed Use.
    Yingst JM; Bordner C; Hrabovsky S; Hobkirk AL; Trushin N; Richie JP; Foulds J
    Nicotine Tob Res; 2024 Feb; 26(3):397-401. PubMed ID: 37434562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of IQOS risk perceptions on cigarette smoking behaviours: results from a prospective pilot study.
    DeAtley T; Stone MD; Strasser AA; Audrain-McGovern J
    Tob Control; 2024 Feb; 33(2):263-266. PubMed ID: 36002165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Switching to the Tobacco Heating System Versus Continued Cigarette Smoking on Chronic Generalized Periodontitis Treatment Outcome: Protocol for a Randomized Controlled Multicenter Study.
    Pouly S; Ng WT; Benzimra M; Soulan A; Blanc N; Zanetti F; Picavet P; Baker G; Haziza C
    JMIR Res Protoc; 2021 Jan; 10(1):e15350. PubMed ID: 33459599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of More Intense Smoking Parameters and Flavor Variety on Toxicant Levels in Emissions of a Heated Tobacco Product.
    Davigo M; Klerx WNM; van Schooten FJ; Opperhuizen A; Remels AHV; Talhout R
    Nicotine Tob Res; 2024 Apr; 26(5):571-579. PubMed ID: 38035623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors that influence smokers' and ex-smokers' use of IQOS: a qualitative study of IQOS users and ex-users in the UK.
    Tompkins CNE; Burnley A; McNeill A; Hitchman SC
    Tob Control; 2021 Jan; 30(1):16-23. PubMed ID: 31941822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat-not-burn tobacco products: a systematic literature review.
    Simonavicius E; McNeill A; Shahab L; Brose LS
    Tob Control; 2019 Sep; 28(5):582-594. PubMed ID: 30181382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Harm of IQOS Smoke to Rat Liver.
    Granata S; Canistro D; Vivarelli F; Morosini C; Rullo L; Mercatante D; Rodriguez-Estrada MT; Baracca A; Sgarbi G; Solaini G; Ghini S; Fagiolino I; Sangiorgi S; Paolini M
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to IQOS ads and reduced exposure claims, and association with perceived risk from COVID-19 on IQOS purchase and use intentions: results from a web-based survey.
    Sharma A; Fix B; Hyland A; Bansal-Travers M; Quisenberry A; O'Connor R
    Front Public Health; 2023; 11():1307484. PubMed ID: 38269390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of reactive carbonyls and superoxide radicals in protein damage by cigarette smoke extracts: Comparison of Heat-not-Burn e-cigarettes to conventional cigarettes.
    Merritt N; Urquhart C; Burcham P
    Chem Biol Interact; 2024 May; 395():111008. PubMed ID: 38636791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective Message Elements for Disclosures About Chemicals in Cigarette Smoke.
    Kelley DE; Boynton MH; Noar SM; Morgan JC; Mendel JR; Ribisl KM; Stepanov I; Nylander-French LA; Brewer NT
    Nicotine Tob Res; 2018 Aug; 20(9):1047-1054. PubMed ID: 28521063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unboxed: US Young Adult Tobacco Users' Responses to a New Heated Tobacco Product.
    Kim M; Watkins SL; Koester KA; Mock J; Kim HC; Olson S; Harvanko AM; Ling PM
    Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33153143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PMI's own in vivo clinical data on biomarkers of potential harm in Americans show that IQOS is not detectably different from conventional cigarettes.
    Glantz SA
    Tob Control; 2018 Nov; 27(Suppl 1):s9-s12. PubMed ID: 30131374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat-not-burn tobacco (IQOS), oral fibroblasts and keratinocytes: cytotoxicity, morphological analysis, apoptosis and cellular cycle. An in vitro study.
    Pagano S; Negri P; Coniglio M; Bruscoli S; Di Michele A; Marchetti MC; Valenti C; Gambelunghe A; Fanasca L; Billi M; Cianetti S; Marinucci L
    J Periodontal Res; 2021 Oct; 56(5):917-928. PubMed ID: 34018192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of FDA endorsement and modified risk versus exposure messaging in IQOS ads: a randomised factorial experiment among US and Israeli adults.
    Berg CJ; Duan Z; Wang Y; Thrasher JF; Bar-Zeev Y; Abroms LC; Romm KF; Khayat A; Levine H
    Tob Control; 2024 Mar; 33(e1):e69-e77. PubMed ID: 36428095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do alternative tobacco products induce less adverse respiratory risk than cigarettes?
    Bhat TA; Kalathil SG; Leigh N; Hutson A; Goniewicz ML; Thanavala YM
    Respir Res; 2023 Oct; 24(1):261. PubMed ID: 37907902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Modified Risk Tobacco Product Claims on Consumer Responses.
    Seidenberg AB; Boynton MH; Brewer NT; Lazard AJ; Sheeran P; Ribisl KM
    Nicotine Tob Res; 2024 Mar; 26(4):435-443. PubMed ID: 37791605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.